Adrian V. S. Hill

University of Oxford - The Jenner Institute

Old Road Campus Research Building Roosevelt Drive

Oxford, Oxfordshire OX3 7DQ

United Kingdom

University of Oxford - Wellcome Trust Centre for Human Genetics

Old Road Campus

Roosevelt Drive

Oxford, OX3 7FZ

United Kingdom

University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine

Oxford

United Kingdom

SCHOLARLY PAPERS

10

DOWNLOADS
Rank 362

SSRN RANKINGS

Top 362

in Total Papers Downloads

84,761

SSRN CITATIONS

9

CROSSREF CITATIONS

3

Scholarly Papers (10)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of São Paulo (UNIFESP), University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, GSK plc, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, University of Liverpool - School of Tropical Medicine, University of Bristol - Bristol Vaccine Centre, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group and Independent
Downloads 52,335 (49)
Citation 3

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - Department of Medicine, University of Oxford - Big Data Institute, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, GSK plc, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Liverpool - School of Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, Genomics England, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Independent and Independent
Downloads 10,927 (898)
Citation 26

Abstract:

Loading...

3.

High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso

Number of pages: 30 Posted: 20 Apr 2021
University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, University of Oxford - The Jenner Institute Laboratories, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Kenya Medical Research Institute (KEMRI), University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute Laboratories, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute Laboratories, University of Oxford - The Jenner Institute Laboratories, London School of Hygiene & Tropical Medicine, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, University of Oxford - Department of Primary Care Health Services, Novavax, Inc., Novavax, Inc., Novavax AB, University of Oxford - The Jenner Institute Laboratories, Serum Institute of India Private Ltd, University of Oxford - The Jenner Institute and Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro
Downloads 9,144 (1,206)

Abstract:

Loading...

4.

Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Number of pages: 35 Posted: 28 Jun 2021
University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Oxford Vaccine Group, GSK plc, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - The Jenner Institute and Independent
Downloads 8,766 (1,292)
Citation 17

Abstract:

Loading...

5.

A Phase III Randomised Controlled Trial Evaluating the Malaria Vaccine Candidate R21/Matrix-M™ in African Children

Number of pages: 25 Posted: 26 Sep 2023
University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, University of Sciences, Technique and Technologies of Bamako (USTTB) - Malaria Research and Training Centre, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institut des Sciences et Techniques (INSTech), Kenya Medical Research Institute (KEMRI) - Centre for Geographical Medicine Research -Coast (KEMRI-CGMRC), Ifakara Health Institute, London School of Hygiene & Tropical Medicine, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, Ifakara Health Institute, West African Network for Clinical Trials of Antimalarial Drugs (WANECAM), University of Sciences, Technique and Technologies of Bamako (USTTB) - Malaria Research and Training Centre, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, University of Oxford - KEMRI-Coast Centre for Geographical Medicine and Research, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, London School of Hygiene & Tropical Medicine, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford - Nuffield Department of Medicine, University of Oxford - The Jenner Institute, London School of Hygiene & Tropical Medicine, GSK plc, London School of Hygiene & Tropical Medicine, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd and University of Oxford - The Jenner Institute
Downloads 2,223 (12,709)
Citation 7

Abstract:

Loading...

malaria, vaccine, safety, efficacy, licensure trial, public health, low-cost, impact on childhood mortality

6.

Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection

Number of pages: 39 Posted: 19 Apr 2021
University of Oxford - Peter Medawar Building for Pathogen Research, GSK plc, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, NIHR Imperial Clinical Research Facility, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University College London - Department of Infection, University of Oxford - The Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, NIHR Guy's and St Thomas' Biomedical Research Centre, Imperial College London - Department of Infectious Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Imperial College London - Department of Infectious Disease, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, Imperial College London - Section of Virology, Guy's and St Thomas' NHS Foundation Trust - Harrison Wing, University of Oxford - The Jenner Institute and Independent
Downloads 656 (74,634)
Citation 2

Abstract:

Loading...

7.

A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in Patients with Active Crohn's Disease

Number of pages: 17 Posted: 22 Dec 2023
Guy’s and St Thomas’ NHS Foundation Trust, University of Oxford, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford, University of Oxford, University of Oxford, University of Oxford, King’s College London - Department of Public Health Sciences, King’s College London, King’s College London, King’s College London, King’s College London, HAV Vaccines Limited, HAV Vaccines Limited, HAV Vaccines Limited, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - The Jenner Institute and affiliation not provided to SSRN
Downloads 338 (164,655)

Abstract:

Loading...

viral vectored vaccines, mycobacterium paratuberculosis, Crohn's Disease, Johne's Disease

8.

The Public Health Impact and Cost-Effectiveness of the R21/Matrix-M Malaria Vaccine: A Mathematical Modelling Study

Number of pages: 26 Posted: 11 Oct 2023
Imperial College London - MRC Centre for Global Infectious Disease Analysis, Imperial College London - MRC Centre for Global Infectious Disease Analysis, Institute de Recherche en Sciences de Santé (IRSS), University of Oxford, Institute de Recherche en Sciences de Santé (IRSS), Institute de Recherche en Sciences de Santé (IRSS), Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, Institute de Recherche en Sciences de Santé (IRSS), Institute de Recherche en Sciences de Santé (IRSS), Institute de Recherche en Sciences de Santé (IRSS), University of Oxford, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Imperial College London - MRC Centre for Global Infectious Disease Analysis, Imperial College London, Institute de Recherche en Sciences de Santé (IRSS), University of Oxford - KEMRI-Coast Centre for Geographical Medicine and Research, Ifakara Health Institute, University of Sciences, Technique and Technologies of Bamako (USTTB) - Malaria Research and Training Centre, Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro, University of Oxford - The Jenner Institute, GSK plc, Imperial College London - MRC Centre for Global Infectious Disease Analysis and Imperial College London - MRC Centre for Global Infectious Disease Analysis
Downloads 274 (204,583)

Abstract:

Loading...

9.

Estimating the Hidden Burden of Iron Deficiency Among African Children

Number of pages: 30 Posted: 17 May 2019
Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of Oxford - Wellcome Centre for Human Genetics, London School of Hygiene & Tropical Medicine - MRC International Statistics and Epidemiology Group, Oxford University Hospitals - Department of Clinical Biochemistry, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University College London - Institute for Global Health, University of the Witwatersrand - Faculty of Health Sciences, Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, London School of Hygiene & Tropical Medicine - Medical Research Council Unit The Gambia, Emory University, London School of Hygiene & Tropical Medicine, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme and Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme
Downloads 52 (692,340)
Citation 2

Abstract:

Loading...

Iron deficiency; Ferritin; Transferrin saturation; Inflammation; Malaria; Malnutrition; African children

10.

Peripheral Blood Myeloid/Platelet:Lymphoid Ratios Predict Mortality Risk Amongst 70,917 Emergency Medical Admissions: A Cohort Study

Number of pages: 29 Posted: 10 Jul 2019
Vivek Naranbhai, Adrian V. S. Hill, A. Sarah Walker and David Wyllie
University of Oxford - Nuffield Department of Medicine, University of Oxford - The Jenner Institute, University of Oxford, Nuffield Department of Medicine, John Radcliffe Hospital and Imperial College London - NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance
Downloads 46 (730,001)

Abstract:

Loading...

leucocyte differential, ratio, myeloid:lymphoid, neutrophil:lymphocyte, monocyte:lymphocyte, platelet:lymphocyte,mortality